Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Envy Medical Introduces Transformative Skincare

Envy Medical logo

News provided by

Envy Medical

Oct 09, 2017, 15:18 ET

Share this article

Share toX

Share this article

Share toX

LONG BEACH, Calif., Oct. 9, 2017 /PRNewswire/ -- Long Beach, California-based skincare pioneers, Envy Medical, are proud to introduce their newest range of skincare, formulated to address age-related concerns including hyperpigmentation, dullness, sagging skin, and fine lines. With extensive renovations to their original formulations, as well as a complete packaging overhaul, Envy Medical's Chief Marketing Officer, Sona Tolani, ensured that the brand's new look and formulas are reflective of what the consumer wants both in terms of visible results and also to display on their vanity shelves.

Envy Medical Introduces Transformative Skincare
Envy Medical Introduces Transformative Skincare

"The brand's original iteration was great, but I wanted to take both its exterior and internal components to another, more elevated level," says Sona Tolani. "We took a very careful and close look at our available technologies and patents, and amplified them in each product's new formula, while overhauling the packaging to give it a sharp and fresh new look. The end result is a product line that outperforms market competitors and also looks great on retail shelves."

To Envy Medical's CEO, Arash Khazei, making sure the brand remained a professionally acclaimed and recognized line was of utmost importance. "I've seen other brands change so drastically that they alienate their existing clientele," he notes. "Our mission and ultimate goal was to remain true to where we began - which was in the professional arena - but also appeal to a broader audience, one that appreciates the very best in skincare and advanced technologies."

The Envy Medical range is now segmented into four offerings geared toward aging skin: Daily Skin Health Maintenance, Skin Brightening, Intensive Skin Brightening, and Skin Brightening & Renewal, with products from each intended to work together for optimal results, based on individual skincare goals. Utilizing patented ingredient technologies and Envy Medical's exclusive Lumixyl® Peptide, researched and developed by Stanford University, regular use of the products results in a brighter, more even complexion that resists the overproduction of melanin.

Included in the new product line are eight new formulations:

ACTIVE-PREP CLEANSER, 6.0oz, $35.00 (Daily Skin Health Maintenance)
Soap-free cleanser recommended for all skin types, that soothes, preps, and cleanses, prepping skin for topical treatments.
Key ingredients: Sandalwood, Chamomile, Aloe Barbadensis, Sage Leaf Extract, Bergamot, and Clover Extract

DERMAL BALANCE, 1.7oz, $60.00 (Daily Skin Health Maintenance)
Calming, multi-functional, hydrating treatment that soothes, shields, and protects skin while improving texture.
Key ingredients: PCX Technology, Active8™ Peptide, and Lavender Oil

LUMIXYL BRIGHTENING CREAM, 1.7 oz, $80.00 (Skin Brightening)
Daily brightening treatment that diminishes existing and prevents future dark spots, while boosting skin hydration and reducing appearance of fine lines.
Key ingredients: Lumixyl Peptide, Meadowfoam Seed Oil, Hyaluronic Acid, Licorice Root Extract, and Aloe Barbadensis Leaf Extract

LUMIXYL BRIGHTENING PADS, 45 pads, $40.00 (Skin Brightening)
Individual pads that exfoliate skin and removes oil and surface debris.
This leave-on treatment reduces the appearance of hyperpigmentation and improves skin texture.
Key ingredients: Lumixyl Peptide, Hyaluronic Acid, Licorice Root Extract, Panthenol, and Aloe Barbadensis Leaf Extract

TRIFECTING NIGHT CREAM, 1.0oz, $85.00 - $95.00 (Intensive Skin Brightening)
Antioxidant-rich nighttime treatment that brightens, softens fine lines, and evens skin tone and texture through enhanced cellular turnover.
Key ingredients: Encapsulated Retinol, Lumixyl Peptide, PCX Technology, Hyaluronic Acid, and Shea Butter
Available in 0.2% and 1.0% concentrations.                     

GLYCOPEEL 10, 1.7oz, $70.00 (Skin Brightening & Renewal)
Leave-on moisturizing treatment that also exfoliates skin using a 10% concentration of Glycolic Acid.
Recommended for those with advanced signs of aging and dryer skin types.
Key ingredients: Glycolic Acid, Lumixyl Peptide, Lactic Acid

REVITALEYES, 0.5oz, $60.00 (Skin Brightening & Renewal)
A potent, all-in-one brightening eye treatment that hydrates, improves tone and texture, and diminishes dark circles around the delicate eye area. Rich in antioxidants, it also helps prevent future damage.
Key ingredients: Lumixyl Peptide, Palmitoyl Tripeptide-1, and Palmitoyl Tetrapeptide-7

While products are formulated to be integrated to a complete skincare routine, they're also ideal complements to Envy Medical's signature professional treatment, Dermalinfusion. This 3-in-1 professional exfoliation treatment eliminates dulling surface matter like dead skin cells, removes it from the epidermis, and infuses skin with a specific serum that addresses dehydration, dullness, uneven skin texture and tone, dark spots, and oily-prone skin. This patented treatment is recommended for all skin types and can be used on most areas of the body, with few contraindications, resulting in more radiant skin, a stimulation in cellular turnover, plumper skin (by 70%) and more. Available in select medical offices, medspas, and spas nationwide.

About Envy Medical: Envy Medical is an advanced skin care system that harnesses scientific knowledge to provide clinically proven, non-invasive skin rejuvenation therapies. Leveraging innovative and patented technologies, Envy Medical's results-oriented, targeted skincare products are consciously formulated to deliver the highest quality ingredients and superior results without compromising skin's delicate balance.

For more information on Envy Medical, please contact Kate Williams at Pistol PR via [email protected] 

SOURCE Envy Medical

Related Links

http://www.envymedical.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.